IL6 and nonpapillary renal cell carcinoma: Our study indicates that elevated serum CRP levels may contribute to CRP levels in ccRCC tissues and that the CRP/CD64 axis induces PD‐L1 and IL6 expression in TAMs, thereby contributing to the progression of ccRCC.